December 28, 2014 12:17 AM ET

Pharmaceuticals

Company Overview of Galileo Pharmaceuticals, Inc.

Company Overview

Galileo Pharmaceuticals, Inc. discovers and develops small molecule therapeutics to treat metabolic and inflammatory diseases. The company develops a pipeline of treatments for diabetes and arthritis. The company was formerly known as Galileo Laboratories, Inc. and changed its name to Galileo Pharmaceuticals, Inc. in April 2003. The company was founded in 1997 and is headquartered in Santa Clara, California.

5301 Patrick Henry Drive

Santa Clara, CA 95054

United States

Founded in 1997

Phone:

408-654-5830

Fax:

408-654-5831

Key Executives for Galileo Pharmaceuticals, Inc.

Director of Finance & Accounting
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Intelligent Nutrients, Inc. United States
Device Partners International, LLC United States
Napo Pharmaceuticals, Inc. United States
Veritas Research Inc. United States
Meritage Pharma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Galileo Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.